Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia

Vascular Medicine (United Kingdom)

Volumn 20, Issue 1, 2015, Pages 14-22

  Ozkor, Muhiddin A ^a   Hayek, Salim S ^a   Rahman, Ayaz M ^a   Murrow, Jonathan R ^a   Kavtaradze, Nino ^a   Lin, Ji ^b   Manatunga, Amita ^b   Quyyumi, Arshed A ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

endothelial function; endothelium derived hyperpolarizing factor; exercise; hypercholesterolemia; nitric oxide; vasodilation

Indexed keywords

CALCIUM CHANNEL; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; TETRYLAMMONIUM; TRIACYLGLYCEROL; BIOLOGICAL FACTOR; CALCIUM ACTIVATED POTASSIUM CHANNEL; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKING AGENT; VASODILATOR AGENT;

ADULT; ARTERIAL PRESSURE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HAND GRIP; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR RESISTANCE; VASODILATATION; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD FLOW; BLOOD FLOW VELOCITY; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; FOREARM; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR; VASCULAR ENDOTHELIUM; VASCULARIZATION; YOUNG ADULT;

ADULT; BIOLOGICAL FACTORS; BLOOD FLOW VELOCITY; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EXERCISE; FEMALE; FOREARM; HUMANS; HYPERCHOLESTEROLEMIA; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; TIME FACTORS; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84924854674     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X14565374     Document Type: Article

References (52)

1. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995 ; 92: 320-326
2. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation. 1994 ; 90: 2853-2858
3. Joannides R, Richard V, Haefeli WE, Linder L, Luscher TF, Thuillez C. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans. Hypertension. 1995 ; 26: 327-331
4. Mullen MJ, Kharbanda RK, Cross J, et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res. 2001 ; 88: 145-151
5. Scotland RS, Madhani M, Chauhan S, et al. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation. 2005 ; 111: 796-803
6. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann Med. 2007 ; 39: 495-516
7. Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 1996 ; 28: 703-711
8. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997 ; 100: 2793-2799
9. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002 ; 23: 374-380
10. Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol. 2004 ; 31: 641-649
11. Inokuchi K, Hirooka Y, Shimokawa H, et al. Role of endothelium-derived hyperpolarizing factor in human forearm circulation. Hypertension. 2003 ; 42: 919-924
12. Miura H, Wachtel RE, Liu Y, et al. Flow-induced dilation of human coronary arterioles: important role of Ca2+-activated K+ channels. Circulation. 2001 ; 103: 1992-1998
13. Ozkor MA, Murrow JR, Rahman AM, et al. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation. 2011 ; 123: 2244-2253
14. Ozkor MA, Rahman AM, Murrow JR, et al. Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites. Arterioscler Thromb Vasc Biol. 2014 ; 34: 1320-1327
15. Laughlin MH, McAllister RM, Jasperse JL, Crader SE, Williams DA, Huxley VH. Endothelium-medicated control of the coronary circulation. Exercise training-induced vascular adaptations. Sports Med. 1996 ; 22: 228-250
16. Hillig T, Krustrup P, Fleming I, Osada T, Saltin B, Hellsten Y. Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans. J Physiol. 2003 ; 546 (Pt 1). 307-314
17. Mortensen SP, Gonzalez-Alonso J, Damsgaard R, Saltin B, Hellsten Y. Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg. J Physiol. 2007 ; 581 (Pt 2). 853-861
18. Schrage WG, Dietz NM, Joyner MJ. Effects of combined inhibition of ATP-sensitive potassium channels, nitric oxide, and prostaglandins on hyperemia during moderate exercise. J Appl Physiol. 2006 ; 100: 1506-1512
19. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 1994 ; 90: 35-41
20. Schrage WG, Joyner MJ, Dinenno FA. Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans. J Physiol. 2004 ; 557 (Pt 2). 599-611
21. Shoemaker JK, Halliwill JR, Hughson RL, Joyner MJ. Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol. 1997 ; 273 (5 Pt 2). H2388-2395
22. Radegran G, Calbet JA. Role of adenosine in exercise-induced human skeletal muscle vasodilatation. Acta Physiol Scand. 2001 ; 171: 177-185
23. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002 ; 106: 653-658
24. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993 ; 87: 1468-1474
25. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995 ; 91: 1732-1738
26. Quyyumi AA, Dakak N, Mulcahy D, et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol. 1997 ; 29: 308-317
27. Taddei S, Galetta F, Virdis A, et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation. 2000 ; 101: 2896-2901
28. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature. 1985 ; 318: 186-188
29. Zelis R, Longhurst J, Capone RJ, Mason DT. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation. 1974 ; 50: 137-143
30. Honing ML, Smits P, Morrison PJ, Rabelink TJ. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension. 2000 ; 35: 1314-1318
31. Stanfield PR. Tetraethylammonium ions and the potassium permeability of excitable cells. Rev Physiol Biochem Pharmacol. 1983 ; 97: 1-67
32. Langton PD, Nelson MT, Huang Y, Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol. 1991 ; 260 (3 Pt 2). H927-934
33. Armstrong RB, Laughlin MH. Rat muscle blood flows during high-speed locomotion. J Appl Physiol. 1985 ; 59: 1322-1328
34. Laughlin MH, Armstrong RB. Muscular blood flow distribution patterns as a function of running speed in rats. Am J Physiol. 1982 ; 243: H296-306
35. Mackie BG, Terjung RL. Blood flow to different skeletal muscle fiber types during contraction. Am J Physiol. 1983 ; 245: H265-275
36. Mohrman DE, Regal RR. Relation of blood flow to VO2, PO2, and PCO2 in dog gastrocnemius muscle. Am J Physiol. 1988 ; 255 (5 Pt 2). H1004-1010
37. Clifford PS, Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol. 2004 ; 97: 393-403
38. Hamann JJ, Buckwalter JB, Valic Z, Clifford PS. Sympathetic restraint of muscle blood flow at the onset of dynamic exercise. J Appl Physiol. 2002 ; 92: 2452-2456
39. Buckwalter JB, Clifford PS. Alpha-adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol. 1999 ; 277 (1 Pt 2). H33-39
40. Buckwalter JB, Mueller PJ, Clifford PS. Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise. J Appl Physiol. 1997 ; 83 (5). 1575-1580
41. Radegran G, Saltin B. Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol. 1999 ; 276 (6 Pt 2). H1951-1960
42. Bradley SJ, Kingwell BA, McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes. 1999 ; 48: 1815-1821
43. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995 ; 268 (4 Pt 1). C799-822
44. Honing ML, Smits P, Morrison PJ, Burnett JC, Rabelink TJ. C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels. Hypertension. 2001 ; 37: 1179-1183
45. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. In vivo evidence for KCa channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol. 2001 ; 132: 443-450
46. Bellien J, Joannides R, Iacob M, Arnaud P, Thuillez C. Calcium-activated potassium channels and NO regulate human peripheral conduit artery mechanics. Hypertension. 2005 ; 46: 210-216
47. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR, Roman RJ. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension. 1997 ; 29 (1 Pt 2)). 320-325
48. Udosen IT, Jiang H, Hercule HC, Oyekan AO. Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels. Am J Physiol Heart Circ Physiol. 2003 ; 285: H2054-2063
49. Miura H, Gutterman DD. Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. Circ Res. 1998 ; 83: 501-507
50. Campia U, Choucair WK, Bryant MB, Quyyumi AA, Cardillo C, Panza JA. Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans. Am J Cardiol. 2002 ; 89: 286-290
51. Halcox JPJ, Narayanan S, Cramer-Joyce L, Mincemoyer R, Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol. 2001 ; 280: H2470-2477
52. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986 ; 8: 37-44